Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cartesian Therapeutics

13.40
-0.3000-2.19%
Post-market: 13.400.00000.00%16:10 EDT
Volume:36.09K
Turnover:484.82K
Market Cap:347.79M
PE:-7.74
High:13.82
Open:13.59
Low:13.26
Close:13.70
Loading ...
Sep 10, 2024

Correspondence

Form CORRESP - Correspondence
Sep 09, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jul 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 05, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Jul 02, 2024

Major Issues Report

Form 8-K - Current report
Jun 17, 2024

Major Issues Report

Form 8-K - Current report
May 22, 2024

Major Issues Report

Form 8-K - Current report
May 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2024

Major Issues Report

Form 8-K - Current report
Apr 22, 2024

Major Issues Report

Form 8-K - Current report
Apr 12, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 10, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Apr 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 28, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Mar 28, 2024

Major Issues Report

Form 8-K - Current report